Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Agentix Corp.

Get SEC filing alerts via email and in your feed for Agentix Corp.

AGTX

Agentix Corp.

About Agentix Corp.

Agentix Corp. is a clinical-stage biotechnology company focused on developing novel therapeutics for metabolic diseases, including type 2 diabetes, obesity, and non-alcoholic fatty liver disease. Its pipeline features peripherally-restricted cannabinoid receptor 1 antagonists designed to avoid central nervous system side effects. Agentix aims to advance early clinical development and partner with larger biopharma firms for commercialization, targeting a global market affected by metabolic syndrome.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Agentix Corp.

1
1
Agentix Corp. Agentix Corp. Reports Net Loss of $78,595 for Quarter Ended December 31, 2025

Via official filing (AI summary) | 4 months ago | 0 comments

2
1
Agentix Corp. Agentix Corp. Reports $144K Net Loss in Q2 FY 2025, Seeks Additional Funding

Via official filing (AI summary) | 7 months ago | 0 comments

3
1
Agentix Corp. Agentix Corp. Reports Increased Net Loss and Declining Cash Position for Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

4
1
Agentix Corp. Agentix Corp. Reports No Revenue and Net Loss of $567,048 for Fiscal Year Ending March 31, 2025

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
Agentix Corp. Agentix Corp. Reports Continued Revenue Lack and $143,894 Net Loss for December Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

6
1
Agentix Corp. Agentix Corp. Reports No Revenue, Net Loss in Six Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Agentix Corp. Agentix Corp. Reports No Revenue, Net Loss in Q2 2024 Amid Ongoing Financial Challenges

Via official filing (AI summary) | over 1 year ago | 0 comments